AlphAIalphai — Financial news for AI agents
SEC EDGARAUG 131 min read$BLBD

Thau Daniel Mark purchased $23K of BLBD

Thau Daniel Mark purchased 350 shares of Blue Bird Corp (BLBD) at $64.37 on 2026-08-12.

Original reporting
SEC EDGAR · Thau Daniel Mark
Published Aug 13, 2026, 3:57 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 4:05 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$BLBD
Bullish
low confidence
Mentioned
$BLBD
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BLBDBullishLow
01

Why it matters

The disclosure may slightly support bullish sentiment, but it does not provide new guidance, contracts, or financial results that would materially reprice the stock.

02

Market read

Traders may note the insider buy, but the filing alone is unlikely to drive a sustained move without additional company-specific catalysts.

03

What to watch

The article does not state whether the director’s broader holdings or prior trading history suggests a pattern, and it notes no pre-arranged 10b5-1 plan.

Relevance 4/10Novelty 3/10Timing: filed 2026-08-13, purchase dated 2026-08-12

Background

This is an SEC Form 4 insider transaction for Blue Bird Corp, reported by a director.

Company-level read

Ticker impact

$BLBDBullishLow confidence
Context

Blue Bird Corp director Thau Daniel Mark bought 350 shares on 2026-08-12 at $64.37, totaling $22,529.50, per Form 4.

Expected impact

Likely limited near-term impact; any effect is sentiment-driven and small versus broader fundamentals.

Evidence & confidence

The filing is a primary insider transaction disclosure, but the transaction size is relatively small and the article provides no accompanying operational or financial update.

Market effects

Sector

No clear sector read-through from a single small insider purchase.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Insider buys can be routine liquidity or diversification actions and may not reflect a change in company outlook.

Key entities

  • issuer
    Blue Bird Corp

    Subject of the Form 4 insider transaction disclosure.

  • insider
    Thau Daniel Mark

    Director who purchased 350 shares open-market on 2026-08-12.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

BLBD insider trading history →

Related articles

AUG 10
$BLBDMed

Why Blue Bird (BLBD) Shares Are Plunging Today

Blue Bird (NASDAQ: BLBD) shares fell 6.4% after Q3 results. The company reported revenue of $517.2M, above analysts’ $498.1M, with 29.9% YoY growth and 42.9% higher sales volume. Adjusted EPS was $1.28 vs $1.30 consensus, and free cash flow margin fell to 4.2% from 13.1%. Guidance was reaffirmed, not raised.

financialcontent.com6 min
AUG 5
$BLBDMedAI 8/10

Blue Bird’s (NASDAQ:BLBD) Q2 CY2026: Beats On Revenue

Blue Bird (NASDAQ:BLBD) reported Q2 CY2026 revenue of $517.2 million, up 29.9% year over year and 3.8% above Wall Street estimates, according to the company. Non-GAAP adjusted EPS was $1.28, up from $1.19 but 1.6% below consensus. The company guided full-year revenue to about $1.75 billion and expected EPS growth to $5.28.

financialcontent.com4 min
AUG 5
$BLBDHigh

Blue Bird Corp (BLBD): Results of Operations and Financial Condition

Blue Bird Corp (BLBD) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a2026q3resultsreleaseex991.htm EX-99.1 Document BLUE BIRD REPORTS FISCAL 2026 THIRD QUARTER RESULTS Net Sales of $517M and GAAP Net Income of $185M Adj. EBITDA of $71M with 14% Margin and 3,525 Buses Sold FY2026 Adj. EBITDA Guidance Raised MACON, Ga. (August 5, 2026) –

SEC EDGAR 8-K6 min
JUL 20
$BLBDMed

Blue Bird (BLBD) Stock Trades Up, Here Is Why

Blue Bird (BLBD) shares rose about 4% to $81.53 after Barclays raised its price target to $85 from $75 and kept an Overweight rating. Barclays cited updated machinery and construction forecasts, production trends, new awards, pricing, and acquisitions, plus Blue Bird’s cash generation and balance sheet. The stock hit an all-time high; analysts noted revenue declines and capacity limits.

financialcontent.com4 min
AUG 24
$CHYMMed

DST Global Advisors Ltd sold $28.1M of CHYM (indirect holdings)

DST Global Advisors Ltd sold 856,725 indirectly-held shares of Chime Financial, Inc. (CHYM) at an average of $32.85 ($32.71–$33.54, $28.14M total) across 21 trades over 2026-08-20 to 2026-08-21. Filed jointly with DST Global VI, L.P. (10% owner), DST Global VII, L.P. (10% owner), DST Investments XXI, L.P. (10% owner), DSTG VI Investments, L.P. (10% owner), DSTG VI Investments-A, L.P. (10% owner), DSTG VII Investments-1, L.P. (10% owner), DSTG VII Investments-4, L.P. (10% owner), DST Managers VI Ltd (10% owner) and DST Managers VII Ltd (10% owner).

SEC EDGAR1 min